Found 2 bookmarks
Newest
If there is a viral reservoir of SARS-CoV-2 why did the Stanford Paxlovid trial fail? The drug might be insufficient, or poor penetration in some reservoirs, or inappropriate end points, etc. Dominique Salmon MD PhD
If there is a viral reservoir of SARS-CoV-2 why did the Stanford Paxlovid trial fail? The drug might be insufficient, or poor penetration in some reservoirs, or inappropriate end points, etc. Dominique Salmon MD PhD
“If there is a viral reservoir of SARS-CoV-2 why did the Stanford Paxlovid trial fail? The drug might be insufficient, or poor penetration in some reservoirs, or inappropriate end points, etc. Dominique Salmon MD PhD”
·x.com·
If there is a viral reservoir of SARS-CoV-2 why did the Stanford Paxlovid trial fail? The drug might be insufficient, or poor penetration in some reservoirs, or inappropriate end points, etc. Dominique Salmon MD PhD
👀 NEW: Stunning interview w former director, virologist Robert Redfield:
👀 NEW: Stunning interview w former director, virologist Robert Redfield:

“Stunning interview w former @CDCgov director, virologist Robert Redfield:

COVID vaccines ‘Do not prevent infection & didn’t impact kinetics of pandemic…They don’t work that well, they’re not durable. What does work better is antiviral drug development [EARLY TX!!!] & we haven’t invested heavily there... Annual flu vaccines only work 25-50% of the time. Vaccines…won’t protect us against bird flu.’”

·x.com·
👀 NEW: Stunning interview w former director, virologist Robert Redfield: